Indications and Purposes
| Indications And Usage For The Acute And Chronic Treatment Of Patients With An Inborn Error Of Metabolism Which Results In Secondary Carnitine Deficiency. For The Prevention And Treatment Of Carnitine Deficiency In Patients With End Stage Renal Disease Who Are Undergoing Dialysis. |
All Formulated Excipients (0 Total)
None
Active Ingredients ( 1 Total)
| Name | Structure | ZINC ID(s) |
|---|---|---|
| 1. Levocarnitine |
|
ZINC3079340 |